Cargando…
Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial
INTRODUCTION: Previous studies of long-term treatment response in fibromyalgia and other chronic pain states have generally been limited to approximately one year, leaving questions about the longer-term durability of response. The purpose of this study was to demonstrate continuing efficacy of miln...
Autores principales: | Clauw, Daniel J, Mease, Philip J, Palmer, Robert H, Trugman, Joel M, Wang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978750/ https://www.ncbi.nlm.nih.gov/pubmed/23953493 http://dx.doi.org/10.1186/ar4268 |
Ejemplares similares
-
Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-controlled withdrawal study
por: Mease, Philip J, et al.
Publicado: (2014) -
Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study
por: Bateman, Lucinda, et al.
Publicado: (2013) -
Milnacipran for the management of fibromyalgia syndrome
por: Ormseth, Michelle J, et al.
Publicado: (2010) -
Effect of milnacipran on body weight in patients with fibromyalgia
por: Arnold, Lesley M, et al.
Publicado: (2012) -
Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Kranzler, Jay D, et al.
Publicado: (2010)